Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NIH Grant to Keystone Nano to Target Nanoparticles to Cancer Cells

Abstract:
KN is pleased to announce that it has been awarded a National Institute of Health (NIH) grant to further develop its nanoparticles for the treatment of cancer. The National Cancer Institute, a part of the NIH, has awarded a grant to Keystone Nano to further develop our siRNA nanoparticle technology.

NIH Grant to Keystone Nano to Target Nanoparticles to Cancer Cells

State College, PA | Posted on March 12th, 2015

Most current chemotherapeutics have are not selective to cancer cells and have dose-limiting toxicities that prevent optimal effects being obtained. Ribonucleic acid interference (RNAi) has the potential to be a safe, selective and personalized treatment approached for a variety of genetic-based diseases, including cancer. In particular, the design of small interfering RNA (siRNA) sequences to prevent the expression of cancer-fueling mutations provides a dramatic alternative to current therapeutic approaches. However, an effective delivery vehicle is required for systemic RNAi therapy to protect siRNA during circulation, concentrate siRNA at tumor sites and mediate cellular uptake as well as endosomal escape. This NIH funded project is designed to optimize a novel, combinatorial RNAi treatment for advanced breast cancer based on delivery by calcium phosphate nanoparticles, called NanoJackets. Building on the demonstrated in vivo efficacy of Keystone Nano's siRNA NanoJackets, an active targeting ligand will be added and evaluated for improved biodistribution, cellular uptake and in vivo efficacy of siRNA NanoJackets for breast cancer therapy. If successful, the development of this targeted, combinatorial RNAi nano-therapeutic will provide a novel option for the personalized treatment of breast cancers that fail to respond to current therapies.

The project will be led by Dr. Mylisa Parette, Research Manager at Keystone Nano and Dr. Carly Carter, Research Team Leader at Keystone Nano. The project is supported by the company's Chief Science Officer, Dr. James Adair, Chief Medical Officer, Dr. Mark Kester, and CEO, Mr. Jeff Davidson.

Based in State College, Keystone Nano is working at the interface between nanotechnology and the life sciences and has licensed intellectual property around nanoparticles from Penn State University. The company is working to commercialize NanoJacket products and Nanoliposomes for a variety of medical applications.

####

For more information, please click here

Contacts:
Jeff Davidson
CEO
814-466-5080

Dr. Mylisa Parette
Research Manager
814-237-4657

Copyright © Keystone Nano

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Cancer

Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025

News and information

INRS and ELI deepen strategic partnership to train the next generation in laser science:PhD students will benefit from international mobility and privileged access to cutting-edge infrastructure June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025

A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025

Govt.-Legislation/Regulation/Funding/Policy

INRS and ELI deepen strategic partnership to train the next generation in laser science:PhD students will benefit from international mobility and privileged access to cutting-edge infrastructure June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025

Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025

Nanomedicine

Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025

Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025

Announcements

INRS and ELI deepen strategic partnership to train the next generation in laser science:PhD students will benefit from international mobility and privileged access to cutting-edge infrastructure June 6th, 2025

Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025

Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025

A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project